Literature DB >> 15039123

Are we making efficient use of clopidogrel?

A Kastrati, A Schömig, E Schömig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15039123     DOI： 10.1016/j.ehj.2004.02.005

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

1.  Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR).

Authors:  L Součková; R Opatřilová; P Suk; I Čundrle; M Pavlík; V Zvoníček; O Hlinomaz; V Šrámek
Journal:  Eur J Clin Pharmacol       Date:  2012-08-14       Impact factor: 2.953

2.  Current concepts on antiplatelet therapy: focus on the novel thienopyridine and non-thienopyridine agents.

Authors:  L Testa; G G L Biondi Zoccai; M Valgimigli; R A Latini; S Pizzocri; S Lanotte; M L Laudisa; N Brambilla; M R Ward; G A Figtree; F Bedogni; R Bhindi
Journal:  Adv Hematol       Date:  2010-12-05

3.  Safety of Antiplatelet Agents: Analysis of 'Real-World' Data from the Italian National Pharmacovigilance Network.

Authors:  Lucia Gozzo; Andrea Navarria; Giuseppe Benfatto; Laura Longo; Silvana Mansueto; Laura Sottosanti; Luca Pani; Salvatore Salomone; Filippo Drago
Journal:  Clin Drug Investig       Date:  2017-11       Impact factor: 2.859

Review 4.  Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities.

Authors:  Akshita Rana; Erik Westein; Be'eri Niego; Christoph E Hagemeyer
Journal:  Front Cardiovasc Med       Date:  2019-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.